SILVER SPRING, MD. – There do not need to be major changes to the warning labels on prescription and over-the-counter nonsteroidal anti-inflammatory medications, said a group of federal advisers on...

Field of Interest: Rheumatology

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.